Bitistatin

N/A

Report date: 2023/04/25 09:12:49

Base Information

Drug NameBitistatin

Drug Alias NameN/A

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionFibrinogen inhibitors

TargetsFibrinogen

Therapy Area/IndicationsThrombosisMyocardial Ischemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerck & Co

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMerck & Co

Active IndicationsN/A

Inactive IndicationsThrombosisMyocardial Ischemia

ATC CodeN/A